SGHT - Sight Sciences, Inc.

QQQ $ 586.18 $ -14.20 (-2.37 %)

DIA $ 458.35 $ -3.66 (-0.79 %)

SPY $ 653.15 $ -10.10 (-1.52 %)

TLT $ 89.26 $ 0.35 (0.39 %)

GLD $ 374.80 $ -0.11 (-0.03 %)

Previous Close

$ 6.64

Open

$ 7.08

Bid

$ 6.61 x 3

Ask

$ 6.64 x 184

Day's Range

$ 6.61 - $ 6.89

52 Week Range

$ 2.03 - $ 8.06

Volume

165,639

Average Volume

Market Cap

366.4M

Beta (5Y Monthly)

$ 1.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	03-07-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-02-2024	06-30-2024	10-Q
7	05-06-2024	03-31-2024	10-Q
8	03-12-2024	12-31-2023	10-K
9	11-07-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-08-2023	03-31-2023	10-Q
12	03-16-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-10-2022	03-31-2022	10-Q
16	03-24-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-12-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Sight Sciences Reports Peer-Reviewed Studi...
11/11/2025 12:18:51

Morgan Stanley Maintains Equal-Weight on S...
11/10/2025 18:13:15

Morgan Stanley analyst Cecilia Furlong maintains Sight Sciences (NASDAQ:SGHT) with a Equal-Weight and raises the price targe...

Piper Sandler Maintains Neutral on Sight S...
11/07/2025 12:47:17

Piper Sandler analyst Adam Maeder maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $4 ...

Sight Sciences Raises FY2025 Sales Guidanc...
11/06/2025 21:07:58

Sight Sciences Q3 EPS $(0.16) Beats $(0.28...
11/06/2025 21:07:15

Sight Sciences Appoints James Rodberg As C...
11/06/2025 21:05:45

Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and c...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Lake Street Maintains Buy on Sight Science...
10/21/2025 14:56:03

Lake Street analyst Frank Takkinen maintains Sight Sciences (NASDAQ:SGHT) with a Buy and raises the price target from $5 to $7.

12 Health Care Stocks Moving In Friday's I...
10/17/2025 17:05:58

Sight Sciences Secures Medicare Pricing Fo...
10/17/2025 11:03:39

Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and com...

Citigroup Maintains Neutral on Sight Scien...
10/07/2025 17:48:36

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and lowers the price target from $4.5...

Sight Sciences Highlights Meta-Analysis Of...
09/17/2025 11:11:50

unitedhealthcare-adds-sight-sciences-omni-system-to-covered-glaucoma-surgery-procedures

UnitedHealthcare Adds Sight Sciences OMNI ...
09/09/2025 15:39:52

UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate o...

Sight Sciences' OMNI Surgical System To Be...
09/09/2025 11:07:22

Sight Sciences Publishes Dry Eye Workshop ...
09/02/2025 20:07:12

Needham Reiterates Hold on Sight Sciencest...
08/28/2025 16:44:29

Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) from Hold to Hold.

What 4 Analyst Ratings Have To Say About S...
08/21/2025 19:00:41

Citigroup Maintains Neutral on Sight Scien...
08/21/2025 18:14:30

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3.6...

Lake Street Upgrades Sight Sciences to Buy...
08/08/2025 22:18:39

Lake Street analyst Frank Takkinen upgrades Sight Sciences (NASDAQ:SGHT) from Hold to Buy and raises the price target from $...

Sight Sciences Raises FY2025 Sales Guidanc...
08/07/2025 20:16:39

Sight Sciences (NASDAQ:SGHT) raises FY2025 sales outlook from $70.000 million-$75.000 million to $72.000 million-$76.000 millio...